𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Decreased oxidation susceptibility of plasma low density lipoproteins in patients with Gilbert's syndrome

✍ Scribed by Zeki Yesilova; Muhittin Serdar; C Nuri Ercin; Alp Gunay; Guldem Kilciler; Adnan Hasimi; Ahmet Uygun; İsmail Kurt; M Kemal Erbil; Kemal Dagalp

Book ID
108951823
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
133 KB
Volume
23
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased susceptibility to oxidation of
Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis
✍ K. Richard Bruckdorfer; Janet B. Hillary; Tim Bunce; Rama Vancheeswaran; Carol M 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 776 KB

Objective. To examine the resistance to oxidation of low-density lipoproteins (LDL) from patients with systemic sclerosis (SSc) and primary Raynaud's phenomenon (RP) compared with healthy controls. Methods. Plasma LDL were isolated from patients with diffuse cutaneous and limited cutaneous SSc (dcS

Decrease of thyroid hormones in patients
Decrease of thyroid hormones in patients with familial hypercholesterolemia during dextran sulphate low-density lipoprotein apheresis
✍ S. Pintus; Dr. P. Pintus; C. Piras; A. Loviselli; S. Muntoni 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Removal of low-density lipoproteins from plasma by dextran sulfate adsorption (DSA) in FH patients entails a decrease in plasma levels of thyroid hormones (-28.5% and -18.78, respectively, for T3 and T4). This suggests that FH patients have a greater than normal fraction of thyroid hormones bound to

Reduction of low-density lipoproteins wi
Reduction of low-density lipoproteins with dextran sulfate in patients with familial hypercholesterolemia
✍ G. Delbert Antwiler; Peter C. Dau; Donn D. Lobdell 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 822 KB

A novel on-line system for the selective precipitation of low-density lipoprotein (LDL) using dextran sulfate has been devised and tested in four patients with heterozygous familial hypercholesterolemia (type 11). The mean pretreatment serum cholesterol was 410 mg/dl. Plasma was generated by membran